About Us

Nebulabio is a cell engineering team specializing in mammalian stable cell line development for research and discovery workflows. By combining standardized project management with flexible technical strategies, we build assay-ready GPCR cell lines with defined expression, consistent signaling behavior, and practical QC—supporting reproducible pharmacology studies across experiments and passages.

Our Stable Cell Line Platform

Our platform supports end-to-end GPCR cell line development, including construct and accessory module design, gene delivery and stable pool establishment, optional monoclonal selection, functional pharmacology validation, QC, and cell banking. The resulting cell lines are engineered to behave as reliable assay systems rather than short-lived expression models.

☞Supported GPCR Stable Cell Line Options

■ Host Cell Lines

• HEK293, CHO, and customer-provided or pathway-relevant lines (feasibility assessment recommended for difficult-to-transfect or slow-growing models)

■ GPCR Expression Formats

• Native (unmodified) receptor expression

• Tagged GPCRs (epitope tags for detection; optional fluorescent tags for trafficking studies)

• Inducible GPCR expression (optional) for toxic receptors, high basal activity, or growth-impacting targets

■ Accessory Proteins & Pathway Support (Optional)

• G protein coupling optimization: specific Gα subunits or chimeric G proteins

• β-arrestin pathway enablement: recruitment or internalization formats

• RAMPs and receptor modifiers: for GPCRs requiring accessory partners for surface expression or signaling

■ Assay-Ready Readout Pairings

• cAMP signaling (Gs / Gi)

• Calcium flux (Gq)

• β-arrestin recruitment or internalization

• Reporter-based outputs (e.g., CRE, SRE, NFAT luciferase)

• Expression confirmation (flow cytometry, IF, WB; ligand binding where applicable)

■ Stable Pools vs. Monoclonal Lines

• Stable pools: rapid setup for feasibility and early screening

• Monoclonal lines: uniform surface expression, tighter CV, screening-grade performance

☞Principle of Stable GPCR Cell Lines

Stable GPCR cell lines are generated by introducing a GPCR expression cassette—optionally combined with pathway or accessory components—into host cells and enriching for populations that maintain receptor expression and functional signaling over long-term culture. Following gene delivery, selective pressure establishes a stable pool, and receptor-positive cells are expanded under conditions that preserve surface expression and signaling competence.

When assay stringency requires greater uniformity, single-cell cloning isolates monoclonal lines with optimized expression, low background, robust ligand responsiveness, and stable pharmacology across passages. This approach produces GPCR models that function as reproducible assay systems rather than transient expression readouts.

☞Nebulabio Service Workflow

☞Featured Applications of GPCR Stable Cell Line Development

• Ligand Discovery and Screening：Stable GPCR cell lines provide consistent, assay-ready platforms for agonist, antagonist, PAM, and NAM screening with reduced variability across plates and experiments.

• Potency and Selectivity Profiling:  Uniform GPCR expression enables reliable EC50/IC50 determination and comparative pharmacology across receptor subtypes or ligands.

• Mechanism-of-Action and Signaling Bias Studies: Stable GPCR models support pathway dissection and bias analysis by enabling parallel G protein and β-arrestin readouts under controlled expression conditions.

• Deorphanization Programs: Stable expression of orphan GPCRs enables systematic ligand testing and functional characterization once suitable assay coupling is established.